- Beat earnings estimates in all of the last 4 quarters
- Excellent financial health (Piotroski 8/9)
- Low bankruptcy risk (Altman Z-Score: 3.34)
Encompass Health Corporation stock price ended at $112.50 on Monday, after gaining 0.258%
(Updated on Jul 20, 2026)
The Encompass Health Corporation stock price gained 0.258% on the last trading day (Monday, 20th Jul 2026), rising from $112.21 to $112.50. During the last trading day the stock fluctuated 1.45% from a day low at $111.35 to a day high of $112.97. The price has been going up and down for this period, and there has been a 5.15% gain for the last 2 weeks. Volume fell on the last day by -151 thousand shares and in total, 791 thousand shares were bought and sold for approximately $88.97 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock has broken the wide and weak rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $110.86, a level that may pose a second chance to hit a runner. According to fan-theory $122.56 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.
EHC Signals & Forecast
Mostly positive signals in the chart today. The Encompass Health Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $110.86 and $104.33. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 17, 2026, and so far it has risen 14.92%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for Encompass Health Corporation stock
Encompass Health Corporation finds support from accumulated volume at $107.48 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.62 between high and low, or 1.45%. For the last week, the stock has had daily average volatility of 2.78%.
The Encompass Health Corporation stock is extremely overbought on RSI14 (83). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.
Our recommended stop-loss: $107.39 (-4.54%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 83 and this increases the risk substantially. There is a buy signal from a pivot bottom found 21 days ago.)
Trading Expectations (EHC) For The Upcoming Trading Day Of Tuesday 21st
For the upcoming trading day on Tuesday, 21st we expect Encompass Health Corporation to open at $112.27, and during the day (based on 14 day Average True Range), to move between $110.95 and $114.05, which gives a possible trading interval of +/-$3.11 (+/-2.80%) up or down from last closing price. If Encompass Health Corporation takes out the full calculated possible swing range there will be an estimated 2.80% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $107.48, some $5.02 (4.46%) from the current price of $112.50, our system finds the risk reward attractive.
Is Encompass Health Corporation stock A Buy?
Several short-term signals, along with a general good trend, are positive and the stock has broken the rising trend up, which indicates an even stronger rate of rising. We can conclude that the current level may hold a buying opportunity as there is a fair chance for Encompass Health Corporation stock to perform well in the short-term period. Due to a possible false trend-break listing stock as pure buy candidate is held back.
Current score:
4.707
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 21, 2026 - $112.27 ( 0.203%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
EHC Performance
Trading levels for EHC
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 113.89 | 1.23% |
| R2 | 113.27 | 0.684% |
| R1 | 112.89 | 0.345% |
| Price | 112.50 | |
| S1 | 111.65 | -0.751% |
| S2 | 111.27 | -1.09% |
| S3 | 110.66 | -1.64% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 112.50 | |
| S1 | 107.48 | -4.46% |
| S2 | 106.64 | -5.21% |
| S3 | 99.84 | -11.25% |
EHC Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | May 07, 2026 | Jul 01, 2026 | Jul 15, 2026 | $0.190 | 0.181% |
| 2 | Feb 19, 2026 | Apr 01, 2026 | Apr 15, 2026 | $0.190 | 0.179% |
| 3 | Jan 02, 2026 | Jan 02, 2026 | Jan 15, 2026 | $0.190 | 0.151% |
| 4 | Jul 24, 2025 | Oct 01, 2025 | Oct 15, 2025 | $0.190 | 0.176% |
| 5 | Jul 01, 2025 | Jul 01, 2025 | Jul 15, 2025 | $0.170 | 0.140% |
FAQ
Click here for our free guide on how to buy Encompass Health Corporation Stock.
Buy EHC